Oter anti-inflammatory and antirheumatic agents, non-steroids

RX_NSAID_OTHER

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC M01AX

79934

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

27810

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

27810

diagram downward connector

Include endpoints None

27810

diagram downward connector
RX_NSAID_OTHER

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 27810 18800 9010
Unadjusted prevalence (%) 7.82 9.48 5.73
Mean age at first event (years) 55.65 54.93 57.13

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 0.92 [0.81, 1.04] 1.9e-1 3224
15 years 0.01 0.84 [0.75, 0.94] 2.8e-3 1901
5 years 0.00 0.77 [0.68, 0.88] 1.2e-4 395
1 year 0.00 0.75 [0.58, 0.98] 3.5e-2 66

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_NSAID_OTHER – Oter anti-inflammatory and antirheumatic agents, non-steroids
GWS hits:

Survival analyses between endpoints

Plot

before Oter anti-inflammatory and antirheumatic agents, non-steroids
after Oter anti-inflammatory and antirheumatic agents, non-steroids

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Oter anti-inflammatory and antirheumatic agents, non-steroids